Want to join the conversation?
For FY17, $CSRA expects revenues of $5-5.2Bil and adjusted diluted EPS of $1.91-2.04. Adjusted EBITDA is expected to be $870-905MM. Free cash flow is expected to be $300-350MM. The adjusted EBITDA and diluted EPS guidance assumes pension income of $96MM. $CSRA expects avg. compound annual growth in revenue of 2-3% and in adjusted EPS of 8-10%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?